DB19296ExperimentalSmall molecule
Linopristin is an antibiotic of the streptogramin B class. It is one part of the combination product NXL 103, along with Virginiamycin M1. The combination product was under investigation in... The combination product was under investigation in clinical trials NCT00653172 and NCT00949130 for treatment of various bacterial infections.
- Formula / weight
- C50H63N9O10 · 950.107 g/mol (avg)
- Also known as
- Nxl-103 component rpr-202868
- Code names
- RPR-202868
Resolves to
Compound
Structure
InChIKey
NVGNYGXBILPHOS-VXNAYKIUSA-NSMILES[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC=C(CN3CCOCC3)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1What you can answer from here — as of March 06, 2025
Which companies are running trials of Linopristin, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account